HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic performance of USPIO-enhanced MRI for lymph-node metastases in different body regions: a meta-analysis.

AbstractOBJECTIVES:
USPIO (ultrasmall superparamagnetic iron oxide contrast agent) MRI was a promising imaging modality in the detection of lymph-node metastases. And this meta-analysis is performed to compare the diagnostic accuracy of USPIO-enhanced MRI with non-enhanced MRI, USPIO-enhanced MRI in various body regions, and postcontrast alone for diagnosis of lymph-node metastases.
METHODS:
A comprehensive and systematic search was conducted in PubMed and EMBASE databases. After a systematic review of the studies, sensitivity, specificity, the Q* value and other measures of accuracy of USPIO-enhanced MRI in the diagnosis of lymph-node metastases were summarized. The overall test performance was based on summary receiver operating characteristic curves.
RESULTS:
Summary of ROC curve analysis for per-lymph-node data shows a pooled sensitivity of 0.90 (95% confidential interval [CI]: 0.88-0.91) and overall specificity of 0.96 (95% CI: 0.95-0.97) for USPIO-enhanced MRI, the Q* value for USPIO-enhanced MRI is 0.9195, diagnostic odds ratio (DOR) is 162.28 (95% CI: 91.82-286.81). Non-enhanced MRI had less overall sensitivity 0.39 (95% CI: 0.34-0.43) and specificity 0.90 (95% CI: 0.89-0.91), respectively, the Q* value for USPIO-enhanced MRI was 0.6321, DOR is 5.81 (95% CI: 3.64-9.82). Postcontrast MRI alone had sensitivity 0.85 (95% CI: 0.81-0.88) and specificity 0.93 (95% CI: 0.91-0.95), respectively, the Q* value for USPIO-enhanced MRI was 0.8976, DOR is 76.92 (95% CI: 34.21-172.93). There was significant heterogeneity for studies reporting enhanced MRI and non-enhanced MRI.
CONCLUSIONS:
This meta-analysis has shown that USPIO-enhanced MRI offers higher diagnostic performance than conventional MRI, and is sensitive and specific for the detection of lymph-node metastases. Postcontrast images alone can equate diagnostic performance pre- and postcontrast MRI has achieved for lymph-node characterization. And the role of USPIO-enhanced MRI in clinical practice still needs to be investigated in future studies.
AuthorsLiucheng Wu, Yunfei Cao, Cun Liao, Jiahao Huang, Feng Gao
JournalEuropean journal of radiology (Eur J Radiol) Vol. 80 Issue 2 Pg. 582-9 (Nov 2011) ISSN: 1872-7727 [Electronic] Ireland
PMID20047813 (Publication Type: Journal Article, Meta-Analysis, Systematic Review)
CopyrightCopyright © 2009 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Contrast Media
  • Dextrans
  • Magnetite Nanoparticles
  • ferumoxtran-10
Topics
  • Contrast Media
  • Dextrans
  • Humans
  • Lymphatic Metastasis (diagnosis)
  • Magnetic Resonance Imaging (methods)
  • Magnetite Nanoparticles
  • ROC Curve
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: